We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current LIFE market cap is 131.44M. The company's latest EPS is USD -0.6692 and P/E is -2.91.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 10.39M | 0 | 0 | 353k |
Operating Income | -13.49M | -7.95M | -12.79M | -13.56M | -12.62M |
Net Income | -13.24M | -7.52M | -11.95M | -12.34M | -11.34M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 422k | 10.46M | 0 | 10.39M |
Operating Income | -32.82M | -22.98M | -15.91M | -34.02M | -46.4M |
Net Income | -34.52M | -23.6M | -16.22M | -33.77M | -45.34M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 96.06M | 95.79M | 136.84M | 132.75M | 125.07M |
Total Liabilities | 19.05M | 24.5M | 27.14M | 26.7M | 26.87M |
Total Equity | 77.01M | 71.28M | 109.7M | 106.05M | 98.2M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 52.75M | 36.19M | 38.73M | 115.54M | 95.79M |
Total Liabilities | 19.1M | 15.16M | 7.24M | 6.41M | 24.5M |
Total Equity | 33.65M | 21.03M | 31.48M | 109.13M | 71.28M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -31.52M | -41.89M | -590k | -12.6M | -22.16M |
Investing | 45.25M | 47.25M | -38.17M | -42.33M | -37.95M |
Financing | 4.53M | 5.45M | 49.5M | 57.51M | 60.2M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -31.06M | -20.01M | -15.3M | -33.08M | -41.89M |
Investing | 37.17M | 4.93M | 6.9M | -91.57M | 47.25M |
Financing | -4.24M | 1.34M | 16.14M | 110.03M | 5.45M |
Market Cap | 131.44M |
Price to Earnings Ratio | -2.91 |
Price to Sales Ratio | 12.72 |
Price to Cash Ratio | 13.24 |
Price to Book Ratio | 1.85 |
Dividend Yield | - |
Shares Outstanding | 67.75M |
Average Volume (1 week) | 613.23k |
Average Volume (1 Month) | 675.58k |
52 Week Change | -0.51% |
52 Week High | 2.6999 |
52 Week Low | 1.0801 |
Spread (Intraday) | 0.05 (2.54%) |
Company Name | aTyr Pharma Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.atyrpharma.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions